References
- Bishop E. H. Pelvic scoring for elective induction. Obstetrics and Gynecologji 1964; 24: 266–268
- Bygdeman M., Christensen N., Green K., Lundström V. Mid-trimester abortion by vaginal adminstration of 9-deoxo-16, 16-dimethyl-9-methylene PGE2. Contraception 1980; 22: 153–164
- Calder A. A. Cervical ripening. Prostaglandins and (heir Inhibitors in Clinical Obstetrics and Gynaecology, M. Bygdeman, G. S. Berger, L. G. Keith. MTP Press, Lancaster 1986; 29–57
- Green K., Bygdeman M., Swabn M. L., Vesterqvist O., Christensen N. J. Development of vaginal gel containing 9-deoxo-16.16-dimethyl-9-methylene PGE2 for cervical dilatation and pregnancy termination. Prostaglandins, Leukotrienes and Essential Fatty Acids 1988; 33: 121–127
- Moberg P. J., Bygdeman M., Carnsjo L. G., Frankman O., Green K. Pre-abortion treatment with a single vaginal suppository containing 9-deoxo-16.16-dimethyl-9-methylene PGE2 in late first and early second trimester pregnancies. Acta Obstetricia et Gynecologica Scandinavica 1983; 137–140, Supplement 113
- Norstrom A. Influence of prostaglandin E, on the biosynthesis of connective tissue constituents in the pregnant human cervix. Prostaglandins 1982; 23: 361–367
- Toppozada M., El-Ghauawi E., Gdweesh S., El-Abd M., Samaha A. Effect of prostaglandins E2 and 15 methyl F2, on human pregnant and non pregnant cervix. European Journal of Obstetrics. Gynecology and Reproductive Biology 1987; 26: 27–32
- Uldbjerg N., Ekman G., Herltoft P., Malmstrom A., Ulmsten U., Wingerup L. Human cervical connective tissue and its reaction to PGE2. Acta Obstetricia et Gynaecologica Scandinavica 1981; 163–166, Supplement 113